The electrical potential difference (A0) across the membrane of Escherichia coli was measured by the distribution of lipid-soluble cations and correlated with resistance to dihydrostreptomycin, where resistance is presumed due to reduced uptake of the drug. A good correlation between the two measured parameters was found under all conditions tested, which included effects of several mutations, inhibitors, changes in pH, and osmolarity. The most dramatic changes were seen when pH was varied; in wild-type strains resistance increased more than 100-fold, and Aip fell by 70 mV when pH was reduced from 8.5 to 5.5. These results were interpreted as support for a model in which the uptake of the polycationic aminoglycosides is electrogenic and therefore driven by AO. The factor common to mutations and conditions which increase resistance was a reduction in A4+. A simple model was developed which relates the miniimal inhibitory concentration to the rate of aminoglycoside uptake and the rate of growth.
The electrical potential difference (A0) across the membrane of Escherichia coli was measured by the distribution of lipid-soluble cations and correlated with resistance to dihydrostreptomycin, where resistance is presumed due to reduced uptake of the drug. A good correlation between the two measured parameters was found under all conditions tested, which included effects of several mutations, inhibitors, changes in pH, and osmolarity. The most dramatic changes were seen when pH was varied; in wild-type strains resistance increased more than 100-fold, and Aip fell by 70 mV when pH was reduced from 8.5 to 5.5. These results were interpreted as support for a model in which the uptake of the polycationic aminoglycosides is electrogenic and therefore driven by AO. The factor common to mutations and conditions which increase resistance was a reduction in A4+. A simple model was developed which relates the miniimal inhibitory concentration to the rate of aminoglycoside uptake and the rate of growth.
Resistance to aminoglycoside antibiotics is associated with a variety of metabolic lesions in bacteria. Mutations producing resistance include ones affecting the synthesis of heme (27, 29) , menaquinone (26, 28) , cytochromes (6, 28) , and the proton-translocating adenosine triphosphatase (ATPase) (19) . Because these mutations do not alter the ribosomal site of aminoglycoside action nor appear to result in inactivation of the antibiotics, it has been assumed that resistance in such mutants is due to reduced uptake of the drugs into the cells. Reduced uptake has been demonstrated in some cases (6, 8, 10, 28) , making this mechanism a reasonable explanation for this type of resistance. This mechanism is of wider interest, for it has been reported in some clinically resistant strains (4) . The coupling between metabolic defects and resistance to aminoglycosides was the subject of this study.
Mutations which produce resistance reduce or abolish the conversion of energy from oxidationreduction reactions in the membrane to the synthesis of ATP or other uses. The connection of resistance with oxidative metabolism is supported by the observation that anaerobic growth is associated with resistance to aminoglycosides (5, 7) . This type of resistance affects all aminoglycosides regardless of specific structure. By contrast, resistance in which R-factor-coded enzymes inactivate the drug or in which the ribosomal site of action is altered by mutation are specific for those aminoglycosides with the requisite structural features (3). Therefore, some relatively nonspecific property of the aminoglycosides must be involved. One common property of all aminoglycosides is a large net positive charge at physiological pH due to multiple amino groups with a high pK. Any positively charged molecule experiences a strong driving force for entry into bacteria which maintain a large electrical potential (A4), interior negative, across their membrane (22) . A reduction in A4 reduces this driving force and could decrease the rate of aminoglycoside uptake to make the cells resistant.
In this study, we examined a number of con- (27) . The mutation in this strain is close to and clockwise from cya near min 85 on the current map of E. coli (2) , indicating it is either a hemC or hemD mutation. Strain TK1207 is unable to grow on succinate, has less than 2% of the ANTIMICROB. AGENTS CHEMOTHER. Antibiotic sensitivity. The minimal inhibitory concentration (MIC) of dihydrostreptomycin was determined by growth on solid medium. Mid-log phase cells were diluted in minimal medium to a concentration of 104/ml, and 0.02 ml of this suspension was spotted on a series of plates, each differing from the next by at most a twofold difference in drug concentration. The MIC is the lowest concentration of drug that prevented growth of any colonies visible with a low-powered (x20) microscope after 24 to 36 h of incubation at 370C.
Electrical potential measurement. The magnitude of the membrane potential was determined from the distribution ratio of lipid-soluble phosphonium ions (25 (14) . RESULTS
The membrane potential in bacteria such as E. coli is generated by the extrusion of protons coupled to oxidative reactions in the cell membrane. This process generates a potential for protons, or protonmotive force (PMF), the term introduced by Mitchell (21) . The PMF consists of an electrical component, represented by A+, and a proton concentration component given by the difference in pH. Because the interior of bacteria is maintained near vH 7.5. there is little difference in pH across the membranes of cells in medium at pH 7.5, so that almost all of the PMF is expressed A4 (22) .
Drugs commonly called uncouplers act to increase the permeability of protons through the membrane, reducing the PMF by discharging it.
At pH 7.5, uncouplers reduce &4. Table 2 shows the effect of 1 mM dinitrophenol on two sensitive strains of E. coli. This concentration of uncoupler reduced the growth rate by 20% and modestly increased resistance to dihydrostreptomy- 20, 1981 cin. Under the same conditions A4 showed a moderate decrease in both strains, suggesting a correlation between AO and drug resistance.
A reduced PMF is associated with some unc mutations (1). Strain TK1207 with the unc-40 mutation is presumed to have a reduced PMF because it has a markedly reduced rate ofproline uptake, a process known to be driven by the PMF (17) . The reduced PMF in such unc strains is due to abnormal leakage of protons through the membrane portion of the proton-translocating ATPase. This leak can be blocked by dicyclohexylcarbodiimide (DCCD) (1, 24). As seen in Table 3 , strain TK1207 had a low AO, that increased in the presence of 0.5 mM DCCD by 30 mV to values typical of wild-type strains. At the same time the MIC was reduced by a factor of 2. As control, we examined strain TK1208 with an unc mutation not associated with a proton leak. In this strain, treatment with DCCD caused no change in MIC and only a slight change in AO', suggesting that the effect of DCCD on strain TK1207 is due to a reduction in the proton leak through the membrane component of the ATPase.
The addition of salt is known to increase resistance to aminoglycosides (20, 30) and to inhibit gentamicin uptake (10) . We found that such resistance was associated with a reduction in A4 in both wild-type and mutant strains (Table 4). In two of the strains 0.5 M NaCl allowed lation between AO and resistance to aminoglycosides.
To simplify the quantitative analysis of our results, we combined data in Fig. 1 and 2 Tables 2 through 4 for the single plot of Fig. 3 . This figure shows the relationship of the logarithm of the MIC to A+p. In spite of some scatter, there is a reasonably good correlation between these two parameters. The solid line in Fig. 3 , drawn by the method of least squares, is log MIC (ug/ml) = 3.3 -0.025 AO (mV). The correlation coefficient, r, is -0.84.
and in
Resistance to two other aminoglycoside antibiotics, kanamycin and neomycin, was also measured under many of the conditions studied here. In each case the relative changes in MIC were identical within experimental error to those observed for dihydrostreptomycin. We thus infer that the correlation between resistance and AO is true for the three aminoglycosides we studied and is probably true for all aminoglycosides. DISCUSSION The mechanism of aminoglycoside uptake is not well understood. Holtje has suggested that uptake is by a transport system for polyamines (18) . This model is not readily reconciled with some findings of Bryan and colleagues (6) , nor with the discordant effects of polyamine starvation on polyamine and aminoglycoside transport (10) . Nor is this model supported by the fact that mutants resistant from loss of a specific transport system have not been reported (8) . Although it is possible that the transport system involved is essential, we prefer the view that aminoglycosides enter by many different transport systems, which have slight affinity for aminoglycosides. Candidates for such uptake include systems for sugars, aminosugars, polyamines, and amino acids. If uptake is by many different systems, any competitive effect by substrates of one system would probably be small, accounting for the failure to observe competition by a large number of substrates each tested singly (8) . We assume that uptake of the polycationic aminoglycosides by all systems is electrogenic so that changes in the driving force have a profound effect on the rate of uptake. For the PMF-driven proline and lactose transport systems of E. coli, it is known that a reduction in the driving force markedly reduces the rate of uptake (23) .
Bryan and colleagues have proposed that aminoglycosides enter cells by transport on quinones or other components of the electron transport chain (8) . More recently, they have modified the model to include AA as the driving force for entry via electron transport components (6) . In our view, the available data do not support any direct role of electron transport, only an indirect role in creating and maintaining A+, which serves as a driving force. The role of AA is strongly supported by our data. Every condition we studied, whether a mutation, addition of an inhibitor, change in external pH, dr change in osmolarity, 20, 1981 showed corresponding changes in resistance and AO. If an electron transport component, for example, a cytochrome, were involved in transport, then the hem mutant we studied would have much higher resistance than would be predicted on the basis of A+, because it would have both a lower driving force and lost the uptake system. Data for the hem mutant fit well the data for other conditions included in Fig. 3 , indicating that such unusual resistance is not seen. The increased sensitivity to and uptake of aminoglycosides in some mutants that overproduce terminal respiratory enzymes are readily explained by the evidence of a greater driving force (6) and therefore do not require any specific role ofthese enzymes in transport. This result states that the concentration ultimately reached in the cell is directly proportional to the influx rate J and inversely proportional to the growth rate k. The MIC is the minimal external concentration at which internal concentration ultimately reaches the lethal concentration. The dependence of C on growth rate explains the well-known fact that rapidly growing bacteria are more resistant to a number of antibiotics, including the aminoglycosides (30) . The effect of growth rate contributes only a part of the variance in the data of Fig. 3 , because growth rates varied by only slightly more than a factor of 2. The major effect seems to be the dependence of J on A+~. This dependence is very steep; the MIC doubles for each 12 mV reduction in AA (Fig. 3) 
